Použitá literatura

  • Neufeld EF and Muenzer J. (2001) The mucopolysaccharidoses. In: The Metabolic and Molecular Bases of Inherited Disease. Scriver CR, Beaudet AL, Sly WS, Valle D, Childs B, Kinzler KW, and Vogelstein B. (eds.). 8th edition, Vol. III. McGraw-Hill, Medical Publishing Division, pp. 3421.
  • Muenzer J. Overview of the mucopolysaccharidoses. Rheumatology 2011;50:v4–v12.
  • Moore D, et al. The prevalence of and survival in Mucopolysaccharidosis I: Hurler, Hurler-Scheie and Scheie syndromes in the UK. Orphanet J Rare Dis 2008;3:24.
  • Beck M et al. The natural history of MPS I: global perspectives from the MPS I Registry. Genet Med. 2014;16(10):759-765.
  • De Ru et al. Capturing phenotypic heterogeneity in MPS I: results of an international consensus procedure. Orphanet Journal of Rare Diseases 2012;7:22.
  • Muenzer J, et al.Mucopolysaccharidosis I: Management and Treatment Guidelines. Pediatrics 2009;123:19–29.
  • Ješina P. Mukopolysacharidóza I v revmatologické ambulanci. Acta Medicinae 2016;7:3-6
  • MPSIDisease.com [online] [cit.01-04-2020]: http://www.mps1disease.com/
  • Michalík J, Zeman J et al. Mukopolysacharidóza. Olomouc: Společnost pro mukopolysacharidosu, 2010. ISBN 978-80-86417-11-0.